The pharmacy services sector saw substantial M&A activity between June 2025 and May 2026, as private equity firms continued to drive consolidation across specialty pharmacy, infusion services, compounding, and pharma services platforms. This activity reflects a strategic shift toward scale, efficiency, and specialization as organizations respond to rising drug costs and evolving U.S. care models. In the U.S., drug spending increased by 11.4%. Looking ahead, specialty therapies—including oncology, autoimmune treatments, and metabolic drugs—are expected to drive renewed increases in drug spending through 2026–2027, even as overall trends temporarily moderate.
Read the full article: Pharmacy M&A in Transition: Key Trends Shaping 2026 //
Source: https://vmghealth.com/insights/blog/pharmacy-ma-in-transition-key-trends-shaping-2026/